Cited by 230SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesCOVID-19 epidemiological studies

The DOI matches its Crossref record; 8 of the 9 references it cites were found in a registry or an index.

What reinfections mean for COVID-19

Open access

Iwasaki, Akiko·2021·The Lancet Infectious Diseases

DOI 10.1016/s1473-3099(20)30783-0PMC PMC7550040

Open this paper in CoChat — free account Open PDF

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/s1473-3099(20)30783-0

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020
Singanayagam, A., Patel, M., Charlett, A., Lopez Bernal, J., Saliba, V., Ellis, J., Ladhani, S., Zambon, M., & Gopal, R. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.32.2001483 · Cited by 846
Seasonal coronavirus protective immunity is short-lasting
Edridge, A. W. D., Kaczorowska, J., Hoste, A. C. R., Bakker, M., Klein, M., Loens, K., Jebbink, M. F., Matser, A., Kinsella, C. M., Rueda, P., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1083-1 · Cited by 767
Genomic evidence for reinfection with SARS-CoV-2: a case study
Tillett, R. L., Sevinsky, J. R., Hartley, P. D., Kerwin, H., Crawford, N. F., Gorzalski, A. J., Laverdure, C., Verma, S. C., Rossetto, C. C., Jackson, D. K., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30764-7 · Cited by 755
Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing
To, K. K.-W., Hung, I. F.-N., Ip, J. D., Chu, A. W.-H., Chan, W.-M., Tam, A. R., Fong, C. H.-Y., Yuan, S., Tsoi, H.-W., Ng, A. C.-K., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1275 · Cited by 746
Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection by a Phylogenetically Distinct Strain
Elslande, J. V., Vermeersch, P., Vandervoort, K., Wawina-Bokalanga, T., Vanmechelen, B., Wollants, E., Laenen, L., André, E., Ranst, M. A. V., Lagrou, K., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1330 · Cited by 271
A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants
Dearlove, B. L., Lewitus, É., Bai, H., Li, Y., Reeves, D. B., Joyce, M. G., Scott, P. T., Amare, M. F., Vasan, S., Michael, N. L., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2008281117 · Cited by 206
Symptomatic SARS-CoV-2 reinfection by a phylogenetically distinct strain.
Elslande, J. V., Vermeersch, P., Vandervoort, K., Wawina-Bokalanga, T., Vanmechelen, B., Wollants, E., Laenen, L., André, E., Ranst, M. A. V., Lagrou, K., et al. (2020) · Clinical Infectious Diseases · Cited by 133
COVID-19 Re-Infection by a Phylogenetically Distinct SARS-CoV-2 Variant, First Confirmed Event in South America.Preprint
Prado-Vivar, B., Becerra-Wong, M., Guadalupe, J. J., Márquez, S., Gutiérrez, B., Rojas‐Silva, P., Grunauer, M., Trueba, G. A., Barragán, V., & Cárdenas, P. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3686174 · Cited by 91

Show all 9 references

Research works printed but not linked: 1

To, 2020, COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing, Clin Infect Dis

Sorted by citations

Immune determinants of COVID-19 disease presentation and severity
Brodin, P. (2021) · Nature Medicine · doi:10.1038/s41591-020-01202-8 · Cited by 670
SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)
Hall, V. J., Foulkes, S., Charlett, A., Atti, A., Monk, E. J. M., Simmons, R., Wellington, E., Cole, M. J., Saei, A., Oguti, B., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00675-9 · Cited by 638
Looking beyond COVID-19 vaccine phase 3 trials
Kim, J. H., Marks, F., & Clemens, J. D. (2021) · Nature Medicine · doi:10.1038/s41591-021-01230-y · Cited by 601
Coronavirus vaccine development: from SARS and MERS to COVID-19
Li, Y.-D., Chi, W.-Y., Su, J.-H., Ferrall, L., Hung, C., & Wu, T. ‐. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-00695-2 · Cited by 486
The first 12 months of COVID-19: a timeline of immunological insights
Carvalho, T., Krammer, F., & Iwasaki, A. (2021) · Nature reviews. Immunology · doi:10.1038/s41577-021-00522-1 · Cited by 483
Self-citation
Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection
Zuo, J., Dowell, A. C., Pearce, H., Verma, K., Long, H. M., Begum, J., Aiano, F., Amin-Chowdhury, Z., Hoschler, K., Brooks, T., et al. (2021) · Nature Immunology · doi:10.1038/s41590-021-00902-8 · Cited by 392
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review
Piechotta, V., Chai, K. L., Valk, S. J., Doree, C. J., Monsef, I., Wood, E. M., Lamikanra, A., Kimber, C., McQuilten, Z., So‐Osman, C., et al. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013600.pub2 · Cited by 372
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Naturally Acquired Immunity versus Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: A Retrospective Cohort Study
Gazit, S., Shlezinger, R., Perez, G., Lotan, R., Peretz, A., Ben-Tov, A., Herzel, E., Alapi, H., Cohen, D., Muhsen, K., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac262 · Cited by 283
“Apart from the paucity of studies examining long-term protection against reinfection [9, 10], there is a challenge in defining reinfection as opposed to prolonged viral shedding [11].”
Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection
Harvey, R. A., Rassen, J. A., Kabelac, C. A., Turenne, W. M., Leonard, S., Klesh, R., Meyer, W. A., Kaufman, H. W., Anderson, S., Cohen, O. J., et al. (2021) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2021.0366 · Cited by 267
Comparison of seroprevalence of SARS-CoV-2 infections with cumulative and imputed COVID-19 cases: Systematic review
Byambasuren, O., Dobler, C. C., Bell, K., Rojas, D. P., Clark, J. M., McLaws, M., & Glasziou, P. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248946 · Cited by 253
Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity
Yahav, D., Yelin, D., Eckerle, I., Eberhardt, C. S., Wang, J., Cao, B., & Kaiser, L. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.11.028 · Cited by 234
COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses
Bonifacius, A., Tischer‐Zimmermann, S., Dragon, A. C., Gussarow, D., Vogel, A., Krettek, U., Gödecke, N., Yılmaz, M., Kraft, A. R. M., Hoeper, M. M., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.01.008 · Cited by 208
Prevalence of antibody positivity to SARS-CoV-2 following the first peak of infection in England: Serial cross-sectional studies of 365,000 adults
Ward, H., Cooke, G., Atchison, C. J., Whitaker, M. D., Elliott, J., Moshe, M., Brown, J. C., Flower, B., Daunt, A., Ainslie, K. E. C., et al. (2021) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2021.100098 · Cited by 198
COVID-19 false dichotomies and a comprehensive review of the evidence regarding public health, COVID-19 symptomatology, SARS-CoV-2 transmission, mask wearing, and reinfection
Escandón-Vargas, K., Rasmussen, A. L., Bogoch, I. I., Murray, E. J., Escandón, K., Popescu, S. V., & Kindrachuk, J. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06357-4 · Cited by 206
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review
Piechotta, V., Iannizzi, C., Chai, K. L., Valk, S. J., Kimber, C., Dorando, E., Monsef, I., Wood, E. M., Lamikanra, A., Roberts, D. J., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013600.pub4 · Cited by 190
COVID‐19 vaccinations: The unknowns, challenges, and hopes
Mohamed, K., Rzymski, P., Islam, M. S., Makuku, R., Mushtaq, A., Khan, A., Ivanovska, M., Makka, S. A., Hashem, F., Marquez, L. P., et al. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27487 · Cited by 151
COVID-19 reinfections among naturally infected and vaccinated individuals
Rahman, S., Rahman, M. M., Miah, M., Begum, M. N., Sarmin, M., Mahfuz, M., Hossain, M. E., Rahman, M. Z., Chisti, M. J., Ahmed, T., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-05325-5 · Cited by 111
Sexual dimorphism in COVID-19: potential clinical and public health implications
Bechmann, N., Barthel, A., Schedl, A., Herzig, S., Varga, Z., Gebhard, C., Mayr, M., Hantel, C., Beuschlein, F., Wolfrum, C., et al. (2022) · Publikationen an der Universität Bielefeld (Universität Bielefeld) · Cited by 110
Sexual dimorphism in COVID-19: potential clinical and public health implications
Bechmann, N., Barthel, A., Schedl, A., Herzig, S., Varga, Z., Gebhard, C., Mayr, M., Hantel, C., Beuschlein, F., Wolfrum, C., et al. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00346-6 · Cited by 123
Fast and noninvasive electronic nose for sniffing out COVID-19 based on exhaled breath-print recognition
Nurputra, D. K., Kusumaatmaja, A., Hakim, M. S., Hidayat, S. N., Julian, T., Sumanto, B., Mahendradhata, Y., Saktiawati, A. M. I., Wasisto, H. S., & Trıyana, K. (2022) · npj Digital Medicine · doi:10.1038/s41746-022-00661-2 · Cited by 111
Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfection
Hanrath, A. T., Payne, B. A. I., & Duncan, C. J. A. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.12.023 · Cited by 103
Do antibody positive healthcare workers have lower SARS-CoV-2 infection rates than antibody negative healthcare workers? Large multi-centre prospective cohort study (the SIREN study), England: June to November 2020Preprint
Hall, V. J., Foulkes, S., Charlett, A., Atti, A., Monk, E., Simmons, R., Wellington, E., Cole, M., Saei, A., Oguti, B., et al. (2021) · medRxiv · doi:10.1101/2021.01.13.21249642 · Cited by 100
The 2020 race towards SARS-CoV-2 specific vaccines
Karpiński, T. M. M., Ożarowski, M., Seremak‐Mrozikiewicz, A., Wolski, H., & Włodkowic, D. (2020) · Theranostics · doi:10.7150/thno.53691 · Cited by 95
A case of SARS-CoV-2 reinfection in Ecuador
Prado-Vivar, B., Becerra-Wong, M., Guadalupe, J. J., Márquez, S., Gutiérrez, B., Rojas‐Silva, P., Grunauer, M., Trueba, G. A., Barragán, V., & Cárdenas, P. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30910-5 · Cited by 176
Blood Biomarkers for Detection of Brain Injury in COVID-19 Patients
DeKosky, S. T., Kochanek, P. M., Valadka, A. B., Clark, R. S. B., Chou, S., Au, A. K., Horvat, C. M., Jha, R. M., Mannix, R., Wisniewski, S. R., et al. (2020) · Journal of Neurotrauma · doi:10.1089/neu.2020.7332 · Cited by 87
Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease
Ricke‐Hoch, M., Stelling, E., Laßwitz, L., Gunesch, A. P., Kasten, M., Belinchón, F. J. Z., Brogden, G., Gerold, G., Battmer, K., Pietschmann, T., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0255335 · Cited by 82
Noncompliance With Safety Guidelines as a Free-Riding Strategy: An Evolutionary Game-Theoretic Approach to Cooperation During the COVID-19 Pandemic
Yong, J. C., & Choy, B. K. C. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.646892 · Cited by 77
Preparing for the Coronavirus Disease (COVID-19) Vaccination: Evidence, Plans, and Implications
Jung, J. (2021) · Journal of Korean Medical Science · doi:10.3346/jkms.2021.36.e59 · Cited by 74
SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity
Nielsen, S. S. F., Vibholm, L. K., Monrad, I., Olesen, R., Frattari, G. S., Pahus, M. H., Højen, J. F., Gunst, J. D., Erikstrup, C., Holleufer, A., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103410 · Cited by 76
Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection
Clarke, C., Prendecki, M. F., Dhutia, A., Gan, J. J. L., Edwards, C., Prout, V., Lightstone, L., Parker, E. L., Marchesin, F., Griffith, M. E., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.03.009 · Cited by 68
A case of COVID-19 reinfection in the UK
West, J., Everden, S., & Nikitas, N. (2020) · Clinical Medicine · doi:10.7861/clinmed.2020-0912 · Cited by 67
Incidence of SARS-CoV-2 infection according to baseline antibody status in staff and residents of 100 long-term care facilities (VIVALDI): a prospective cohort study
Krutikov, M., Palmer, T., Tut, G., Fuller, C., Shrotri, M., Williams, H., Davies, D., Irwin-Singer, A., Robson, J., Hayward, A. C., et al. (2021) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(21)00093-3 · Cited by 64
Risk of Reinfection After Seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Population-based Propensity-score Matched Cohort Study
Leidi, A., Koegler, F., Dumont, R., Dubos, R., Zaballa, M.-E., Piumatti, G., Coen, M., Berner, A., Farhoumand, P. D., Vetter, P., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab495 · Cited by 62
Microglial Implications in SARS-CoV-2 Infection and COVID-19: Lessons From Viral RNA Neurotropism and Possible Relevance to Parkinson’s Disease
Awogbindin, I. O., Ben‐Azu, B., Olusola, B. A., Akinluyi, E. T., Adeniyi, P. A., Paolo, T. D., & Tremblay, M. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.670298 · Cited by 61
A review of mathematical model-based scenario analysis and interventions for COVID-19
Padmanabhan, R., Abed, H. S., Meskin, N., Khattab, T. M., Shraim, M., & Al-Hitmi, M. A. E. (2021) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2021.106301 · Cited by 65
Multiple COVID-19 Waves and Vaccination Effectiveness in the United States
Lin, L., Zhao, Y., Chen, B., & He, D. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19042282 · Cited by 62
Reinfection rates among patients previously infected by SARS-CoV-2: systematic review and meta-analysis
Mao, Y., Wang, W., Ma, J., Wu, S., & Sun, F. (2021) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001892 · Cited by 60
SARS-CoV-2: vaccines in the pandemic era
Li, D., & Li, Q. (2021) · Military Medical Research · doi:10.1186/s40779-020-00296-y · Cited by 61
Do Antibody Positive Healthcare Workers Have Lower SARS-CoV-2 Infection Rates than Antibody Negative Healthcare Workers? Large Multi-Centre Prospective Cohort Study (The SIREN Study), England: June to November 2020Preprint
Hall, V. J., Foulkes, S., Charlett, A., Atti, A., Monk, E. J. M., Simmons, R., Wellington, E., Cole, M. J., Saei, A., Oguti, B., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3768524 · Cited by 59
The Incidence of SARS-CoV-2 Reinfection in Persons With Naturally Acquired Immunity With and Without Subsequent Receipt of a Single Dose of BNT162b2 Vaccine
Gazit, S., Shlezinger, R., Perez, G., Lotan, R., Peretz, A., Ben‐Tov, A., Herzel, E., Alapi, H., Cohen, D., Muhsen, K., et al. (2022) · Annals of Internal Medicine · doi:10.7326/m21-4130 · Cited by 55
Dynamics of a Dual SARS-CoV-2 Lineage Co-Infection on a Prolonged Viral Shedding COVID-19 Case: Insights into Clinical Severity and Disease Duration
Pedro, N., Silva, C., Magalhães, A. C., Cavadas, B., Rocha, A. M., Moreira, A. C., Gomes, M. S., Silva, D., Sobrinho‐Simões, J., Ramos, A., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9020300 · Cited by 53
Incorporating Social Determinants of Health into Modelling of COVID-19 and other Infectious Diseases: A Baseline Socio-economic Compartmental Model
Galanis, G., & Hanieh, A. (2021) · Social Science & Medicine · doi:10.1016/j.socscimed.2021.113794 · Cited by 54
Analysis of the Potential Efficacy and Timing of COVID-19 Vaccine on Morbidity and Mortality
Haghpanah, F., Lin, G., Levin, S. A., & Klein, E. Y. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.100863 · Cited by 57
The prevalence of adaptive immunity to COVID-19 and reinfection after recovery – a comprehensive systematic review and meta-analysis
Chivese, T., Matizanadzo, J. T., Musa, O. A. H., Hindy, G., Furuya‐Kanamori, L., Islam, N., Al-Shebly, R., Shalaby, R., Habibullah, M., Al-Marwani, T. A., et al. (2022) · Pathogens and Global Health · doi:10.1080/20477724.2022.2029301 · Cited by 54
Ct values and infectivity of SARS-CoV-2 on surfaces
Kampf, G., Lemmen, S., & Suchomel, M. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30883-5 · Cited by 52
Impaired anti-SARS-CoV-2 antibody response in non-severe COVID-19 patients with diabetes mellitus: A preliminary report
Pal, R., Sachdeva, N. K., Mukherjee, S., Suri, V., Zohmangaihi, D., Ram, S., Puri, G. D., Bhalla, A., Soni, S. L., Pandey, N., et al. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.12.035 · Cited by 52
Convalescent plasma for people with COVID-19: a living systematic review
Iannizzi, C., Chai, K. L., Piechotta, V., Valk, S. J., Kimber, C., Monsef, I., Wood, E. M., Lamikanra, A., Roberts, D. J., McQuilten, Z., et al. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013600.pub5 · Cited by 45
Recommendations for the use of COVID-19 vaccines in patients with immune-mediated kidney diseases
Kronbichler, A., Anders, H., Juarez, G. M. F., Floege, J., Goumenos, D. S., Segelmark, M., Tesař, V., Türkmen, K., van Kooten, C., & Bruchfeld, A. N. (2021) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfab064 · Cited by 46
Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection
Marchi, S., Viviani, S., Remarque, E. J., Ruello, A., Bombardieri, E., Bollati, V., Milani, G. P., Manenti, A., Lapini, G., Rebuffat, A., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0253977 · Cited by 43
Immunology of COVID ‐19
Brüssow, H. (2020) · Environmental Microbiology · doi:10.1111/1462-2920.15302 · Cited by 54
Vaccination passports: Challenges for a future of air transportation
Sun, X., Wandelt, S., & Zhang, A. (2021) · Transport Policy · doi:10.1016/j.tranpol.2021.06.018 · Cited by 41
The mystery of COVID-19 reinfections: A global systematic review and meta-analysis
Dhillon, R. A., Qamar, M. A., Gilani, J. A., Irfan, O., Waqar, U., Sajid, M. I., & Mahmood, S. F. (2021) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2021.103130 · Cited by 40
Airborne infection risks of SARS-CoV-2 in U.S. schools and impacts of different intervention strategies
Xu, Y., Cai, J., Shuai, L. I., He, Q., & Zhu, S. (2021) · Sustainable Cities and Society · doi:10.1016/j.scs.2021.103188 · Cited by 42
Convalescent plasma for people with COVID-19: a living systematic review
Iannizzi, C., Chai, K. L., Piechotta, V., Valk, S. J., Kimber, C., Monsef, I., Wood, E. M., Lamikanra, A., Roberts, D. J., McQuilten, Z., et al. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013600.pub6 · Cited by 41
The SARS-CoV-2 pandemic: remaining uncertainties in our understanding of the epidemiology and transmission dynamics of the virus, and challenges to be overcome
Anderson, R. M., Vegvari, C., Hollingsworth, T. D., Pi, L., Maddren, R., Ng, C. W., & Baggaley, R. F. (2021) · Interface Focus · doi:10.1098/rsfs.2021.0008 · Cited by 38
Modeling the COVID-19 pandemic: a primer and overview of mathematical epidemiology
Saldaña, F., & Velasco‐Hernández, J. X. (2021) · SeMA Journal · doi:10.1007/s40324-021-00260-3 · Cited by 39
Dynamics of SARS-CoV-2 with waning immunity in the UK population
Crellen, T., Pi, L., Davis, E. L., Pollington, T. M., Lucas, T. C. D., Ayabina, D. V., Borlase, A., Toor, J., Prem, K., Medley, G. F., et al. (2021) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2020.0274 · Cited by 30
Repeated SARS-CoV-2 Positivity: Analysis of 123 Cases
Váncsa, S., Dembrovszky, F., Farkas, N., Szakó, L., Teutsch, B., Bunduc, Ș., Nagy, R., Párniczky, A., Erőss, B. M., Péterfi, Z., et al. (2021) · Viruses · doi:10.3390/v13030512 · Cited by 33
Prolonged viral shedding and antibody persistence in patients with COVID-19
Fotouhi, F., Salehi-Vaziri, ‪., Farahmand, B., Mostafavi, E., Pouriayevali, M. H., Jalali, T., Mazaheri, V., Larijani, M. S., Tavakoli, M., Mohammadnejad, A. E., et al. (2021) · Microbes and Infection · doi:10.1016/j.micinf.2021.104810 · Cited by 31
Acceptance of a vaccine against COVID-19 – a systematic review of surveys conducted worldwide
Snehota, M., Vlčková, J., Čížková, K., Vachutka, J., Kolarova, H., Klaskova, E., & Kollárová, H. (2021) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2021_086 · Cited by 31
Evaluation of the United States COVID-19 vaccine allocation strategy
Islam, M. R., Oraby, T. F., McCombs, A., Chowdhury, M. M., Al-Mamun, M. A., Tyshenko, M. G., & Kadelka, C. (2021) · PLoS ONE · doi:10.1371/journal.pone.0259700 · Cited by 34
Clinical characteristics of SARS-CoV-2 by re-infection vs. reactivation: a case series from Iran
Salehi-Vaziri, ‪., Jalali, T., Farahmand, B., Fotouhi, F., Banifazl, M., Pouriayevali, M. H., Larijani, M. S., Afzali, N., & Ramezani, A. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-021-04221-6 · Cited by 30
Regression Models for Understanding COVID-19 Epidemic Dynamics With Incomplete Data
Quick, C., Dey, R., & Lin, X. (2021) · Journal of the American Statistical Association · doi:10.1080/01621459.2021.2001339 · Cited by 28
COVID-19 Research: Lessons from Non-Human Primate Models
Albrecht, L., Bishop, E., Jay, B., Lafoux, B., Minoves, M., & Passaes, C. (2021) · Vaccines · doi:10.3390/vaccines9080886 · Cited by 30
COVID-19 diverse outcomes: Aggravated reinfection, type I interferons and antibodies
Silva, R. C. M. C., Bandeira‐Melo, C., Neto, H. A. P., Vale, A. M., & Travassos, L. H. (2022) · Medical Hypotheses · doi:10.1016/j.mehy.2022.110943 · Cited by 36
COVID-19 Testing and the Impact of the Pandemic on the Miami Adult Studies on HIV Cohort
Tamargo, J. A., Martin, H. R., Diaz‐Martinez, J., Trepka, M. J., Delgado‐Enciso, I., Johnson, A., Mandler, R. N., Siminski, S. M., Gorbach, P. M., & Baum, M. K. (2021) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002680 · Cited by 27
Key Considerations for the Development of Safe and Effective SARS‐CoV‐2 Subunit Vaccine: A Peptide‐Based Vaccine Alternative
Shalash, A. O., Hussein, W. M., Skwarczyński, M., & Tóth, I. (2021) · Advanced Science · doi:10.1002/advs.202100985 · Cited by 25
Re‐infection in COVID‐19: Do we exaggerate our worries?
Arslan, Y., Akgül, F., Sevim, B., Varol, Z. S., & Tekin, S. (2022) · European Journal of Clinical Investigation · doi:10.1111/eci.13767 · Cited by 25
Hybrid immunity against reinfection with SARS-CoV-2 following a previous SARS-CoV-2 infection and single dose of the BNT162b2 vaccine in children and adolescents: a target trial emulation
Gazit, S., Saciuk, Y., Perez, G., Peretz, A., Ben‐Tov, A., Stuart, E. A., & Patalon, T. (2023) · The Lancet Microbe · doi:10.1016/s2666-5247(23)00103-9 · Cited by 25
A 1 to 1000 SARS-CoV-2 reinfection proportion in members of a large healthcare provider in Israel: a preliminary reportPreprint
Perez, G., Banon, T., Gazit, S., Moshe, S. B., Wortsman, J., Grupel, D., Peretz, A., Ben‐Tov, A., Chodick, G., Mizrahi-Reuveni, M., et al. (2021) · medRxiv · doi:10.1101/2021.03.06.21253051 · Cited by 24
Suspected Recurrent SARS-CoV-2 Infections Among Residents of a Skilled Nursing Facility During a Second COVID-19 Outbreak — Kentucky, July–November 2020
Cavanaugh, A. M., Thoroughman, D. A., Miranda, H., & Spicer, K. B. (2021) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7008a3 · Cited by 25
The Impact of Increasing Disease Prevalence, False Omissions, and Diagnostic Uncertainty on Coronavirus Disease 2019 (COVID-19) Test Performance
Kost, G. J. (2021) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2020-0716-sa · Cited by 23
Longitudinal SARS-CoV-2 antibody study using the Easy Check COVID-19 IgM/IgG™ lateral flow assay
Higgins, R. L., Rawlings, S. A., Case, J., Lee, F., Chan, C. W., Barrick, B. L., Burger, Z. C., Yeo, K.-T. J., & Marrinucci, D. C. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247797 · Cited by 24
Public views about COVID-19 ‘Immunity Passports’
Hall, M. A., & Studdert, D. M. (2021) · Journal of Law and the Biosciences · doi:10.1093/jlb/lsab016 · Cited by 22
The REinfection in COVID‐19 Estimation of Risk (RECOVER) study: Reinfection and serology dynamics in a cohort of Canadian healthcare workers
Racine, É., Boivin, G., Longtin, Y., McCormack, D., Decaluwe, H., Savard, P., Cheng, M. P., Hamelin, M., Carbonneau, J., Tadount, F., et al. (2022) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12997 · Cited by 18
Persistent viral RNA shedding in COVID-19: Caution, not fear
Plebani, M. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103234 · Cited by 22
Protective Effect of Melatonin Administration against SARS-CoV-2 Infection: A Systematic Review
Molina‐Carballo, A., Palacios-López, R., Jerez-Calero, A. E., Augustin-Morales, M. D. C., Agil, A., Muñoz‐Hoyos, A., & Muñoz-Gallego, A. (2021) · Current Issues in Molecular Biology · doi:10.3390/cimb44010003 · Cited by 20
From Isolation to Containment: Perceived Fear of Infectivity and Protective Behavioral Changes during the COVID-19 Vaccination Campaign
Kaim, A., Siman‐Tov, M., Jaffe, E., & Adini, B. B. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18126503 · Cited by 19
COVID-19 reinfection in Liberia: Implication for improving disease surveillance
Akpan, G. E., Bawo, L., Amo-Addae, M. P., Kennedy, J. B. M., Wesseh, C. S., Whesseh, F., Adewuyi, P. A., Blebo, L. S., Babalola, J., Wilson, H. W., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265768 · Cited by 19
Analysis of multi-strain infection of vaccinated and recovered population through epidemic model: Application to COVID-19
Otunuga, O. M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0271446 · Cited by 18
Drug-Based Therapeutic Strategies for COVID-19-Infected Patients and Their Challenges
Zarkesh, K., Entezar-Almahdi, E., Ghasemiyeh, P., Akbarian, M., Bahmani, M., Roudaki, S., Fazlinejad, R., Mohammadi‐Samani, S., Firouzabadi, N., Hosseini, M., et al. (2021) · Future Microbiology · doi:10.2217/fmb-2021-0116 · Cited by 18
An immune correlate of SARS-CoV-2 infection and severity of reinfectionsPreprint
Maier, H. E., Balmaseda, Á., Ojeda, S., Cerpas, C., Sánchez, N., Plazaola, M., van Bakel, H., Kubale, J., López, R., SABORÍO, S. I., et al. (2021) · medRxiv · doi:10.1101/2021.11.23.21266767 · Cited by 16
RETRACTED: Understanding the implications of SARS-CoV-2 re-infections on immune response milieu, laboratory tests and control measures against COVID-19
Mustapha, J. O., Abdullahi, I. N., Ajagbe, O., Emeribe, A. U., Fasogbon, S. A., Onoja, S. O., Ugwu, C. E., Umeozuru, C. M., Ajayi, F. O., Tanko, W. N., et al. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e05951 · Cited by 17
Retracted
Virtual screening of functional foods and dissecting their roles in modulating gene functions to support post COVID‐19 complications
Afroz, S., Fairuz, S., Joty, J. A., Uddin, M. N., & Rahman, M. A. (2021) · Journal of Food Biochemistry · doi:10.1111/jfbc.13961 · Cited by 16
Developing an Effective Peptide-Based Vaccine for COVID-19: Preliminary Studies in Mice Models
Yang, H., Cao, J. A., Lin, X., Yue, J., Zieneldien, T., Kim, J., Wang, L., Fang, J., Huang, R., Bai, Y., et al. (2022) · Viruses · doi:10.3390/v14030449 · Cited by 18
Reinfection of SARS-CoV-2 – analysis of 23 cases from the literature
Roberts, A. T., Piani, F., Longo, B., Andreini, R., & Meini, S. (2021) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2021.1905174 · Cited by 17
SARS-CoV-2 Reinfection among Healthcare Workers in Mexico: Case Report and Literature Review
Garduño-Orbe, B., Sánchez-Rebolledo, J. M., Cortés-Rafael, M., García-Jiménez, Y., Perez-Ortiz, M., Mendiola-Pastrana, I. R., López‐Ortiz, E., & López-Ortiz, G. (2021) · Medicina · doi:10.3390/medicina57050442 · Cited by 16
Hyperimmune immunoglobulin for people with COVID-19
Kimber, C., Valk, S. J., Chai, K. L., Piechotta, V., Iannizzi, C., Monsef, I., Wood, E. M., Lamikanra, A., Roberts, D. J., McQuilten, Z., et al. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015167.pub2 · Cited by 16
SARS-CoV-2 reinfections during the first three major COVID-19 waves in Bulgaria
Marinov, G. K., Mladenov, M., Rangachev, A., & Alexiev, I. (2022) · PLoS ONE · doi:10.1371/journal.pone.0274509 · Cited by 14
Recurrent and persistent infection with SARS-CoV-2 – epidemiological data and case reports from Western Sweden, 2020
Ringlander, J., Olausson, J., Nyström, K., Härnqvist, T., Jakobsson, H. E., & Lindh, M. (2021) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2021.1957143 · Cited by 14
Wastewater-based modeling, reconstruction, and prediction for COVID-19 outbreaks in Hungary caused by highly immune evasive variants
Polcz, P., Tornai, K., Juhász, J., Cserey, G., Surján, G., Pándics, T., Róka, E., Vargha, M., Reguly, I. Z., Csikász‐Nagy, A., et al. (2023) · Water Research · doi:10.1016/j.watres.2023.120098 · Cited by 14
A Case Series Describing the Recurrence of COVID-19 in Patients Who Recovered from Initial Illness in Bangladesh
Das, P., Satter, S. M., Ross, A. G., Abdullah, Z., Nazneen, A., Sultana, R., Rimi, N. A., Chowdhury, K. I. A., Alam, M. R., Parveen, S., et al. (2021) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed6020041 · Cited by 13
Coronavirus new variants: the mutations cause and the effect on the treatment and vaccination
Raheem, R., Alsayed, R., Yousif, E. A., & Hairunisa, N. (2021) · Baghdad Journal of Biochemistry and Applied Biological Sciences · doi:10.47419/bjbabs.v2i02.54 · Cited by 13
Evaluating COVID-19 Booster Vaccination Strategies in a Partially Vaccinated Population: A Modeling Study
Massonnaud, C., Roux, J., Colizza, V., & Crépey, P. (2022) · Vaccines · doi:10.3390/vaccines10030479 · Cited by 15
Dynamics of Naturally Acquired Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 in Children and Adolescents
Patalon, T., Saciuk, Y., Hadad, H. O., Peretz, A., Peretz, A., Ben‐Tov, A., & Gazit, S. (2023) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2023.02.016 · Cited by 13
Clinical Features and Time to Recovery of Admitted COVID-19 Cases at Dilla University Referral Hospital Treatment Center, South Ethiopia
Churiso, G., Diriba, K., Girma, H., & Tafere, S. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s356606 · Cited by 12
Assessment of neutralizing antibody responses after natural SARS-CoV-2 infection and vaccination in congolese individuals
Batchi-Bouyou, A. L., Djontu, J. C., Vouvoungui, C., Mapanguy, C. C. M., Ingoba, L. L., Mougany, J. S., Boumpoutou, R. K., Diafouka-Kietela, S., Ampa, R., & Ntoumi, F. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07593-y · Cited by 12
Mathematical modelling of the second wave of COVID-19 infections using deterministic and stochastic SIDR models
Lobato, F. S., Libotte, G. B., & Platt, G. M. (2021) · Nonlinear Dynamics · doi:10.1007/s11071-021-06680-0 · Cited by 13
Modelling how face masks and symptoms-based quarantine synergistically and cost-effectively reduce SARS-CoV-2 transmission in Bangladesh
Ferguson, E. A., Brum, E., Chowdhury, A., Chowdhury, S., Kundegorski, M. E., Mahmud, A. S., Purno, N. H., Sania, A., Steenson, R., Tasneem, M., et al. (2022) · Epidemics · doi:10.1016/j.epidem.2022.100592 · Cited by 14
COVID‐19 Reinfection in a Patient Receiving Immunosuppressive Treatment for Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
Gulati, K., Prendecki, M. F., Clarke, C., Willicombe, M. K., & McAdoo, S. P. (2021) · Arthritis & Rheumatology · doi:10.1002/art.41671 · Cited by 11

Authors: Iwasaki, A.
Affiliations: Howard Hughes Medical Institute (US)
Corresponding author: Iwasaki, Akiko
ORCID: Iwasaki, Akiko
Venue: The Lancet Infectious Diseases
Publisher: Elsevier BV
Published: 2021-01
Volume: 21
Issue: 1
Pages: 3-5
ISSN: 1473-3099 (ISSN-L)
DOI: 10.1016/s1473-3099(20)30783-0
PMC: PMC7550040
OpenAlex: W3092033637
Cited by: 230
References: 9
Citations by year: 2026: 1 · 2025: 1 · 2024: 8 · 2023: 19 · 2022: 46 · 2021: 136
FWCI: 7.22
Type: journal article
Language: en
Update notices: erratum (2021-01-01)
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: The Lancet Infectious Diseases (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
Keywords: COVID-19 pandemic, SARS-CoV-2, reinfection, immune response, protective immunity, duration of immunity
MeSH terms: Reinfection, COVID-19, SARS-CoV-2, Humans, Recurrence, Genomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

What reinfections mean for COVID-19

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks